Skip to content

Evaluation Study on Corneal Lens for Vision Correction

Evaluation Study on Corneal Lens for Vision Correction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02053688
Enrollment
40
Registered
2014-02-04
Start date
2013-02-28
Completion date
2013-12-31
Last updated
2014-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The objective of this study is to evaluate the fitting and visual outcomes of Nexis Lens, made of silicone commonly used in the contact lens industry, on healthy eye with or without astigmatism.

Interventions

DEVICEAstigmatic Correction Lens (Nexis ACCL lenses)

Astigmatic refractive error correction

DEVICEToric Soft Contact Lenses

astigmatism correction using toric optics

Sponsors

FORSIGHT Vision3
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient with good corneal health 2. Age 18-65. 3. Patients able to understand the requirements of the study and willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements. 4. Best corrected visual acuity of 20/20 or better in the study eye/s

Exclusion criteria

1. Any other anterior segment abnormality. 2. No previous corneal procedures, including Laser Vision Correction. 3. Any abnormalities associated with the eye lids. 4. Clinically significant inflammation or infection within six (6) months prior to study. 5. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator. 6. Participation in any study involving an investigational drug or device within the past 30 calendar days, or ongoing participation in a study with an investigational material except studies using corneal lenses. 7. Intolerance or hypersensitivity to topical anesthetics, fluorescein, or components of the material. 8. Specifically known intolerance or hypersensitivity to contact lenses. 9. Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient.

Design outcomes

Primary

MeasureTime frame
Visual Acuity30 mins

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026